National Vision Holdings Cash Flow from Investing Activities 2015-2024 | EYE
National Vision Holdings cash flow from investing activities from 2015 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
| National Vision Holdings Annual Cash Flow Investing (Millions of US $) |
|
|---|---|
| 2023 | $-116 |
| 2022 | $-111 |
| 2021 | $-93 |
| 2020 | $-76 |
| 2019 | $-101 |
| 2018 | $-104 |
| 2017 | $-95 |
| 2016 | $-91 |
| 2015 | $-80 |
| 2014 | $-56 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.113B | $2.126B |
| National Vision Holdings, Inc. is one of the leading and rapidly growing optical retailers in the U.S. It provides budget-friendly eye exams, eyeglasses and contact lenses to low-income consumers and aims at making eye care and eyewear reasonable for all Americans. The company operates through a diverse portfolio of retail stores across brands and consumer websites. The company uses third-party carriers to transport all products from the distribution centers to the destination. It operates through 2 reportable segments. Owned & host segment includes the company's owned brands, namely, America's Best and Eyeglass World along with its Vista Optical locations in Fred Meyer stores. National Vision also provides affordable eye care products and services to American military service members within the owned & host segment. Legacy segment comprises National Vision's old strategic collaboration with Walmart to run to Vision Centers in certain Walmart stores. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $175.233B | 22.94 |
| Stryker (SYK) | United States | $129.957B | 31.13 |
| Boston Scientific (BSX) | United States | $110.003B | 35.04 |
| Medtronic (MDT) | Ireland | $108.204B | 15.64 |
| EssilorLuxottica (ESLOY) | France | $99.874B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $39.398B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.127B | 27.83 |
| ResMed (RMD) | United States | $30.257B | 28.41 |
| Koninklijke Philips (PHG) | Netherlands | $25.296B | 19.60 |
| Terumo (TRUMY) | Japan | $25.163B | 35.54 |
| Zimmer Biomet Holdings (ZBH) | United States | $23.688B | 15.13 |
| Baxter (BAX) | United States | $16.913B | 12.02 |
| Insulet (PODD) | United States | $12.064B | 53.49 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.877B | 0.00 |
| Demant (WILYY) | Denmark | $10.259B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.130B | 26.59 |
| BellRing Brands (BRBR) | United States | $7.607B | 35.78 |
| Lantheus Holdings (LNTH) | United States | $5.529B | 13.78 |
| GN Store Nord (GNNDY) | Denmark | $4.717B | 26.49 |
| Haemonetics (HAE) | United States | $4.448B | 21.98 |
| Perrigo (PRGO) | Ireland | $3.708B | 11.24 |
| Envista Holdings (NVST) | United States | $3.128B | 12.91 |
| Prestige Consumer Healthcare (PBH) | United States | $3.126B | 14.87 |
| QuidelOrtho (QDEL) | United States | $2.927B | 16.25 |
| Neogen (NEOG) | United States | $2.853B | 27.44 |
| TG Therapeutics (TGTX) | United States | $2.528B | 71.13 |
| ICU Medical (ICUI) | United States | $2.464B | 21.75 |
| Green Thumb Industries (GTBIF) | United States | $2.303B | 45.62 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.250B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $2.157B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.765B | 51.74 |
| Warby Parker (WRBY) | United States | $1.662B | 0.00 |
| InMode (INMD) | Israel | $1.576B | 8.38 |
| Verano Holdings (VRNOF) | United States | $1.342B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.331B | 9.89 |
| Owens & Minor (OMI) | United States | $1.329B | 11.58 |
| AtriCure (ATRC) | United States | $1.028B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.994B | 0.00 |
| Evolus (EOLS) | United States | $0.791B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.735B | 15.65 |
| Canopy Growth (CGC) | Canada | $0.714B | 0.00 |
| Quanterix (QTRX) | United States | $0.619B | 0.00 |
| Valneva SE (VALN) | France | $0.619B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.617B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.612B | 14.39 |
| Surmodics (SRDX) | United States | $0.600B | 37.59 |
| PetIQ (PETQ) | United States | $0.594B | 19.19 |
| Jin Medical (ZJYL) | China | $0.476B | 0.00 |
| ZimVie (ZIMV) | United States | $0.444B | 37.84 |
| TerrAscend (TSNDF) | Canada | $0.434B | 0.00 |
| Biote (BTMD) | United States | $0.417B | 9.60 |
| OraSure Technologies (OSUR) | United States | $0.346B | 11.14 |
| Aurora Cannabis (ACB) | Canada | $0.337B | 0.00 |
| Cerus (CERS) | United States | $0.325B | 0.00 |
| Zynex (ZYXI) | United States | $0.318B | 43.56 |
| Viemed Healthcare (VMD) | United States | $0.273B | 27.00 |
| Sanara MedTech (SMTI) | United States | $0.265B | 0.00 |
| MacroGenics (MGNX) | United States | $0.259B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.241B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.240B | 15.11 |
| TriSalus Life Sciences (TLSI) | United States | $0.204B | 0.00 |
| Omeros (OMER) | United States | $0.191B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.179B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.178B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.153B | 73.30 |
| Veru (VERU) | United States | $0.146B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.08 |
| FitLife Brands (FTLF) | United States | $0.142B | 20.13 |
| Quipt Home Medical (QIPT) | United States | $0.141B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.117B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.106B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 8.30 |
| Brainsway (BWAY) | Israel | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.082B | 0.00 |
| MariMed (MRMD) | United States | $0.082B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.077B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.055B | 0.00 |
| Safety Shot (SHOT) | United States | $0.055B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.055B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.049B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.043B | 2.83 |
| United-Guardian (UG) | United States | $0.042B | 15.25 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 0.00 |
| Agape ATP (ATPC) | $0.020B | 0.00 | |
| Innovative Eyewear (LUCY) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |